Literature DB >> 18812316

The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptor.

Melissa J S Chee1, Karin Mörl, Diana Lindner, Nicole Merten, Gerald W Zamponi, Peter E Light, Annette G Beck-Sickinger, William F Colmers.   

Abstract

Constitutively active G-protein-coupled receptors (GPCRs) can signal even in the absence of ligand binding. Most Class I GPCRs are stabilized in the resting conformation by intramolecular interactions involving transmembrane domain (TM) 3 and TM6, particularly at loci 6.30 and 6.34 of TM6. Signaling by Gi/Go-coupled receptors such as the Neuropeptide Y1 receptor decreases already low basal metabolite levels. Thus, we examined constitutive activity using a biochemical assay mediated by a Gi/Gq chimeric protein and a more direct electrophysiological assay. Wild-type (WT-Y1) receptors express no measurable, agonist-independent activation, while mu-opioid receptors (MOR) and P2Y12 purinoceptors showed clear evidence of constitutive activation, especially in the electrophysiological assay. Neither point mutations at TM6 (T6.30A or N6.34A) nor substitution of the entire TM3 and TM6 regions from the MOR into the Y1 receptor increased basal WT-Y1 activation. By contrast, chimeric substitution of the third intracellular loop (ICL3) generated a constitutively active, Y1-ICL3-MOR chimera. Furthermore, the loss of stabilizing interactions from the native ICL3 enhanced the role of surrounding residues to permit basal receptor activation; because constitutive activity of the Y1-ICL3-MOR chimera was further increased by point mutation at locus 6.34, which did not alter WT-Y1 receptor activity. Our results indicate that the ICL3 stabilizes the Y1 receptor in the inactive state and confers structural properties critical for regulating Y receptor activation and signal transduction. These studies reveal the active participation of the ICL3 in the stabilization and activation of Class I GPCRs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812316      PMCID: PMC2662261          DOI: 10.1074/jbc.M804671200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

2.  The structural evolution of a P2Y-like G-protein-coupled receptor.

Authors:  Angela Schulz; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2003-06-30       Impact factor: 5.157

3.  A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell.

Authors:  Inaki Azpiazu; N Gautam
Journal:  J Biol Chem       Date:  2004-04-12       Impact factor: 5.157

4.  Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain.

Authors:  Bin Tu; Olga Timofeeva; Yiqun Jiao; J Victor Nadler
Journal:  J Neurosci       Date:  2005-02-16       Impact factor: 6.167

5.  Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats.

Authors:  Dwayne N Jackson; Kevin J Milne; Earl G Noble; J Kevin Shoemaker
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

6.  Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor.

Authors:  Carl P Nelson; Stefan R Nahorski; R A John Challiss
Journal:  J Pharmacol Exp Ther       Date:  2005-09-27       Impact factor: 4.030

7.  The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.

Authors:  Bouchaïb El Bahh; Silvia Balosso; Trevor Hamilton; Herbert Herzog; Annette G Beck-Sickinger; Günther Sperk; Donald R Gehlert; Annamaria Vezzani; William F Colmers
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

Review 8.  NPY and Y receptors: lessons from transgenic and knockout models.

Authors:  Shu Lin; Dana Boey; Herbert Herzog
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

9.  Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.

Authors:  Carlos Timossi; Carmen Ortiz-Elizondo; David B Pineda; James A Dias; P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Mol Cell Endocrinol       Date:  2004-08-31       Impact factor: 4.102

10.  Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors.

Authors:  Remko A Bakker; Paola Casarosa; Henk Timmerman; Martine J Smit; Rob Leurs
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

View more
  16 in total

1.  Structural basis of activation of bitter taste receptor T2R1 and comparison with Class A G-protein-coupled receptors (GPCRs).

Authors:  Nisha Singh; Sai Prasad Pydi; Jasbir Upadhyaya; Prashen Chelikani
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

2.  Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation.

Authors:  Rhian M Evans; Haitao You; Shahid Hameed; Christophe Altier; Alexandre Mezghrani; Emmanuel Bourinet; Gerald W Zamponi
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

3.  Covalent agonists for studying G protein-coupled receptor activation.

Authors:  Dietmar Weichert; Andrew C Kruse; Aashish Manglik; Christine Hiller; Cheng Zhang; Harald Hübner; Brian K Kobilka; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-08       Impact factor: 11.205

4.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug.

Authors:  Kaihua Zhang; Jin Zhang; Zhan-Guo Gao; Dandan Zhang; Lan Zhu; Gye Won Han; Steven M Moss; Silvia Paoletta; Evgeny Kiselev; Weizhen Lu; Gustavo Fenalti; Wenru Zhang; Christa E Müller; Huaiyu Yang; Hualiang Jiang; Vadim Cherezov; Vsevolod Katritch; Kenneth A Jacobson; Raymond C Stevens; Beili Wu; Qiang Zhao
Journal:  Nature       Date:  2014-03-23       Impact factor: 49.962

5.  Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors.

Authors:  Gregory V Nikiforovich; Christina M Taylor; Garland R Marshall; Thomas J Baranski
Journal:  Proteins       Date:  2010-02-01

6.  Nociceptin/orphanin FQ suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus.

Authors:  Melissa J Chee; Christopher J Price; Michael A Statnick; William F Colmers
Journal:  J Physiol       Date:  2011-04-18       Impact factor: 5.182

7.  Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12.

Authors:  Philipp Schmidt; Lars Ritscher; Elizabeth N Dong; Thomas Hermsdorf; Maxi Cöster; Doreen Wittkopf; Jens Meiler; Torsten Schöneberg
Journal:  Mol Pharmacol       Date:  2012-10-23       Impact factor: 4.436

Review 8.  Regulation of Ca(V)2 calcium channels by G protein coupled receptors.

Authors:  Gerald W Zamponi; Kevin P M Currie
Journal:  Biochim Biophys Acta       Date:  2012-10-12

9.  Neuropeptide Y tonically inhibits an NMDAR➔AC1➔TRPA1/TRPV1 mechanism of the affective dimension of chronic neuropathic pain.

Authors:  Weisi Fu; Caitlin R Wessel; Bradley K Taylor
Journal:  Neuropeptides       Date:  2020-01-24       Impact factor: 3.286

10.  SEB-3, a CRF receptor-like GPCR, regulates locomotor activity states, stress responses and ethanol tolerance in Caenorhabditis elegans.

Authors:  C Jee; J Lee; J P Lim; D Parry; R O Messing; S L McIntire
Journal:  Genes Brain Behav       Date:  2012-09-04       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.